Volpi S, Ambroni M, Buzzetti R , Cimino G, Gramegna A, Lucanto MC, Ripani R, Ros M , Salvatore D , Spada E, Braggion C, on behalf of the Italian SITTMA Study Group. Real-World Safety and Effectiveness of Elexacaftor, Tezacaftor, and Ivacaftor in People with Cystic Fibrosis and Advanced Lung Disease: A Two-Year Multicenter Cohort Study. International Journal of Molecular Sciences, 2025;26,10513.
Articolo
-
-
Buzzetti R. Contare per raccontare il Covid-19. Ricerca & Pratica, 2025;41:77-79
-
Costa S, Buzzetti R. Conoscere ed interpretare le differenze –LONG-TERM OUTCOMES OF EARLY EXPOSURE TO REPEATED GENERAL ANAESTHESIA IN CHILDREN WITH CYSTIC FIBROSIS (CF-GAIN): A MULTICENTRE, OPEN-LABEL, RANDOMIZED CONTROLLED PHASE 4 TRIAL. Orizzonti FC, 2024;20 (3):33-36
-
Costa S, Buzzetti R. Conoscere ed interpretare le differenze –A RANDOMIZED TRIAL OF ORAL PREDNISONE FOR CYSTIC FIBROSIS PULMONARY EXACERBATION TREATMENT. Orizzonti FC, 2024;20 (3):37-39
-
Nazzari E, Buzzetti R, Romano M. Conoscere ed interpretare le differenze – Commenti ad articoli della letteratura: Azithrom ycin for early Pseudomonas infection in cystic fibrosis . The OPTIMIZE randomized trial. Orizzonti FC, 2018;15(3):30-34
-
Nazzari E, Buzzetti R, Palleschi A. Conoscere ed interpretare le differenze – Commenti ad articoli della letteratura: A 3-year prognostic score for adults with cystic fibrosis. Orizzonti FC, 2018;15(3):34-38
-
Cirilli N, Buzzetti R, Costa S, Magrì M, Graziano L, Cialfi S, Alghisi F, Majo F, Ficili F, Magazzù G, Samaja M, on behalf of IPaCOR Working Group. Cataloguing outcome measures of cystic fibrosis clinical studies. Journal of Cystic Fibrosis, 2019;S135
-
Villa R, Buzzetti R. Peter Doshi non ha tutti i torti (ma qualcuno forse sì). Scienza in Rete 2021
-
R. Buzzetti, L. Minicucci, N. Cirilli, V. Raia, D. Salvatore, A. Daniele. CFDB – CYSTIC FIBROSIS DATABASE CHE COSA È E COME FUNZIONA. Orizzonti FC, 2022;19 (3):33-36
-
Galici V, Buzzetti R, Tabarini P. Conoscere ed interpretare le differenze – Commenti ad articoli della letteratura. SELF-MANAGEMENT INTERVENTION TO REDUCE PULMONARY EXACERBATIONS BY SUPPORTING TREATMENT ADHERENCE IN ADULTS WITH CYSTIC FIBROSIS: A RANDOMIZED CONTROLLED TRIAL. Orizzonti FC, 2022;19 (2):25-29
© 2022 Roberto Buzzetti - P. iva: 02926830163 - Developed by Onlime